Soin Therapeutics Completes Formulation Development of Novel Low Dose Naltrexone Tablet to Treat Complex Regional Pain Syndrome
Post Views: 113 Soin Therapeutics, a biotechnology company based in Dayton, OH, has completed the formulation development work of their novel, proprietary low dose naltrexone pill to treat Complex Regional Pain Syndrome (CRPS). CRPS is a debilitating, orphan disease characterized by severe chronic pain, swelling, and hypersensitivity to touch- among other undesirable symptoms which typically…
